1-[2-Fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione - CAS 1150560-54-5
Catalog: |
BB003472 |
Product Name: |
1-[2-Fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione |
CAS: |
1150560-54-5 |
Synonyms: |
1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-5-iodo-6-methylpyrimidine-2,4-dione; 1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-5-iodo-6-methylpyrimidine-2,4-dione |
IUPAC Name: | 1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-5-iodo-6-methylpyrimidine-2,4-dione |
Description: | 1-[2-Fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione (CAS# 1150560-54-5) is an intermediate in the synthesis of Elagolix, a gonadotropin-releasing hormone antagonist (GnRH) used in the treatment of endometriosis. |
Molecular Weight: | 428.12 |
Molecular Formula: | C13H9F4IN2O2 |
Canonical SMILES: | CC1=C(C(=O)NC(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)I |
InChI: | InChI=1S/C13H9F4IN2O2/c1-6-10(18)11(21)19-12(22)20(6)5-7-8(13(15,16)17)3-2-4-9(7)14/h2-4H,5H2,1H3,(H,19,21,22) |
InChI Key: | TZBUKGISILNJCR-UHFFFAOYSA-N |
Storage: | Keep in dark place, Sealed in dry, 2-8 °C |
LogP: | 3.06810 |
GHS Hazard Statement: | H302 (20%): Harmful if swallowed [Warning Acute toxicity, oral]; H312 (20%): Harmful in contact with skin [Warning Acute toxicity, dermal]; H315 (80%): Causes skin irritation [Warning Skin corrosion/irritation]; H320 (80%): Causes eye irritation [Warning Serious eye damage/eye irritation]; H332 (20%): Harmful if inhaled [Warning Acute toxicity, inhalation]; H361 (80%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] |
Precautionary Statement: | P203, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P318, P321, P330, P332+P317, P337+P317, P362+P364, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112125855-A | Synthesis method of oxaagolide intermediate 1- (2-fluoro-6-trifluoromethylbenzyl) -5-iodo-6-methyluracil | 20200925 |
WO-2021130776-A1 | An improved process for the preparation of 4-({(1 r)-2-[5-(2-fluoro-3methoxyphenyl)-3-{[2-fluoro-6-(trifluoro methyl) phenyl]methyl}-4-methyl-2,6-dioxo-3,6dihydropyrimidin-1(2 h)-yl]-1-phenylethyl}amino)butanoic acid or its pharmaceutically acceptable salts | 20191227 |
US-2021078956-A1 | Process for preparing elagolix sodium and intermediates thereof | 20190918 |
WO-2021054896-A1 | Process for preparing elagolix sodium and intermediates thereof | 20190918 |
WO-2020194115-A1 | Process for the preparation of elagolix sodium and intermediates thereof | 20190325 |
Complexity: | 521 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 427.96449 |
Formal Charge: | 0 |
Heavy Atom Count: | 22 |
Hydrogen Bond Acceptor Count: | 6 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 427.96449 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 49.4 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
-
[875573-66-3]
Estra-1,3,5(10)-triene-3,17-diol,7-(9-bromononyl)-,17-acetate,(7a,17b)-
-
[286961-14-6]
N-Boc-1,2,3,6-tetrahydropyridine-4-boronic Acid Pinacol Ester
-
[1184173-73-6]
MK-8353
-
[75726-96-4]
2-Bromo-N-isopropylacetamide
-
[35153-16-3]
(Z)-10-Tetradecenyl Acetate
-
[133407-82-6]
MG-132
INDUSTRY LEADERS TRUST OUR PRODUCTS